Rite Aid Stock Price, News & Analysis (NYSE:RAD)

Rite Aid trades on the New York Stock Exchange (NYSE) under the ticker symbol "RAD."

Rite Aid's stock reverse split on the morning of Monday, April 22nd 2019. The 1-20 reverse split was announced on Wednesday, April 10th 2019. The number of shares owned by shareholders was adjusted after the closing bell on Friday, April 19th 2019. An investor that had 100 shares of Rite Aid stock prior to the reverse split would have 5 shares after the split.

Rite Aid Co. (NYSE:RAD) issued its earnings results on Wednesday, June, 26th. The company reported ($0.14) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.02 by $0.16. The business earned $5.37 billion during the quarter, compared to analysts' expectations of $5.37 billion. Rite Aid had a negative net margin of 3.40% and a negative return on equity of 1.08%. During the same quarter in the prior year, the firm earned ($0.20) earnings per share. View Rite Aid's Earnings History.

Rite Aid is scheduled to release their next quarterly earnings announcement on Thursday, September 26th 2019. View Earnings Estimates for Rite Aid.

Rite Aid will be holding an earnings conference call on Thursday, September 26th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

Rite Aid updated its FY 2020 earnings guidance on Wednesday, June, 26th. The company provided earnings per share (EPS) guidance of $-0.14-0.72 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $-0.02. The company issued revenue guidance of $21.5-21.9 billion, compared to the consensus revenue estimate of $21.6 billion.

5 analysts have issued 1-year price targets for Rite Aid's shares. Their predictions range from $5.00 to $20.00. On average, they anticipate Rite Aid's stock price to reach $15.00 in the next year. This suggests a possible upside of 97.1% from the stock's current price. View Analyst Price Targets for Rite Aid.

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Rite Aid in the last year. There are currently 3 sell ratings and 2 hold ratings for the stock, resulting in a consensus recommendation of "Sell." View Analyst Ratings for Rite Aid.

Headlines about RAD stock have trended somewhat negative on Monday, according to InfoTrie. InfoTrie rates the sentiment of media coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Rite Aid earned a coverage optimism score of -1.3 on InfoTrie's scale. They also gave news stories about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the company's share price in the next several days. View News Stories for Rite Aid.

Rite Aid saw a drop in short interest in August. As of August 31st, there was short interest totalling 13,975,700 shares, a drop of 5.5% from the July 31st total of 14,790,400 shares. Based on an average daily trading volume, of 2,560,000 shares, the short-interest ratio is presently 5.5 days. Currently, 26.9% of the shares of the company are short sold. View Rite Aid's Current Options Chain.

Some companies that are related to Rite Aid include Covetrus (CVET), Diplomat Pharmacy (DPLO), 111 (YI), Petmed Express (PETS), China Jo-Jo Drugstores (CJJD), HealthWarehouse.com (HEWA) and Dougherty's Pharmacy (MYDP).

Based on aggregate information from My MarketBeat watchlists, some companies that other Rite Aid investors own include Century Aluminum (CENX), Celgene (CELG), Akorn (AKRX), Bank of America (BAC), Mr. Cooper Group (COOP), Cleveland-Cliffs (CLF), Advanced Micro Devices (AMD), Lantronix (LTRX), General Electric (ge) and AK Steel (AKS).

Rite Aid's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (10.17%), BlackRock Inc. (7.53%), Invesco Ltd. (4.88%), Morgan Stanley (3.68%), Alberta Investment Management Corp (2.33%) and Allianz Asset Management GmbH (2.07%). View Institutional Ownership Trends for Rite Aid.

RAD stock was sold by a variety of institutional investors in the last quarter, including Vanguard Group Inc., BlackRock Inc., JPMorgan Chase & Co., Alberta Investment Management Corp, APG Asset Management N.V., Allianz Asset Management GmbH, Northern Trust Corp and Charles Schwab Investment Management Inc.. View Insider Buying and Selling for Rite Aid.

RAD stock was bought by a variety of institutional investors in the last quarter, including Morgan Stanley, KLS Diversified Asset Management LP, A.R.T. Advisors LLC, Cubist Systematic Strategies LLC, Renaissance Technologies LLC, Voloridge Investment Management LLC, PARK CIRCLE Co and Invesco Ltd.. View Insider Buying and Selling for Rite Aid.

Shares of RAD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of RAD stock can currently be purchased for approximately $7.61.

Rite Aid has a market capitalization of $409.49 million and generates $21.64 billion in revenue each year. Rite Aid employs 51,000 workers across the globe.View Additional Information About Rite Aid.

The official website for Rite Aid is http://www.riteaid.com/.

Rite Aid's mailing address is 30 Hunter Lane, Camp Hill PA, 17105. The company can be reached via phone at 717-761-2633 or via email at [email protected]